Biosenta Inc.
ZRO
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.67% | 0.00% | -42.86% | 24,366.67% | -40.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.67% | 0.00% | -42.86% | 24,366.67% | -40.00% |
| Cost of Revenue | -83.33% | -83.33% | -83.33% | -98.11% | -87.45% |
| Gross Profit | 118.18% | 117.39% | 113.04% | 666.02% | 90.43% |
| SG&A Expenses | -5.41% | -26.16% | -25.79% | -13.96% | 11.97% |
| Depreciation & Amortization | 58.33% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.81% | -26.22% | -26.33% | -14.10% | 10.38% |
| Operating Income | 7.84% | 26.27% | 26.34% | 28.08% | -10.41% |
| Income Before Tax | 63.50% | 64.81% | 65.11% | -1,449.37% | -1,060.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 63.50% | 64.81% | 65.11% | -1,449.37% | -1,060.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.50% | 64.81% | 65.11% | -1,449.37% | -1,060.69% |
| EBIT | 7.84% | 26.27% | 26.34% | 28.08% | -10.41% |
| EBITDA | -561.90% | -- | -- | -- | -- |
| EPS Basic | 62.23% | 62.24% | 60.69% | -501.07% | -447.38% |
| Normalized Basic EPS | -11.42% | -15.26% | -29.93% | 0.32% | -19.12% |
| EPS Diluted | 62.23% | 62.24% | 60.69% | -501.07% | -447.38% |
| Normalized Diluted EPS | -11.42% | -15.26% | -29.93% | 0.32% | -19.12% |
| Average Basic Shares Outstanding | 12.15% | 11.74% | 9.69% | 38.55% | 31.92% |
| Average Diluted Shares Outstanding | 12.15% | 11.74% | 9.69% | 38.55% | 31.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |